Advertisement

Topics

CHU - Hôpitaux de Rouen Company Profile

18:45 EDT 24th September 2016 | BioPortfolio

Nil

Location

1 rue de Germont
Rouen
76031
France

Contact

Phone: 02 32 88 89 90
Email: maitre-toile@chu-rouen.fr


News Articles [11 Associated News Articles listed on BioPortfolio]

BRIEF-Mauna Kea Technologies gets new Cellvizio order for Rouen University Hospital

* New Cellvizio order placed by UGAP for Rouen University Hospital Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

MAUNA KEA TECHNOLOGIES ANNONCE UNE NOUVELLE COMMANDE UGAP DE CELLVIZIO POUR LE CHU DE ROUEN

PARIS, le 30 Juin 2016 /PRNewswire/ -- Deuxième commande de Cellvizio par l'UGAP depuis le début de l'année  Mauna Kea Technologies (Euronext : MKEA, FR0010609263, Read more...

AMYOTROPHIE SPINALE: L'exosquelette qui fait marcher les enfants - CSIC

C'est le premier exosquelette du monde développé pour les enfants atteints d'amyotrophie spinale. L'objectif, est non seulement d'aider les enfants à marcher, et parfois pour la p...

Study demonstrates possibility of changing behavior of gaze by transcranial magnetic stimulation

A study financed by the Assistance Publique-Hôpitaux de Paris has been conducted under the direction of Monica Zilbovicius in the Inserm Unit 1000 on a particular region of the brain, the superior te...

VIH-Sida: Tat Oyi, le candidat vaccin prometteur testé à Marseille - Retrovirology

Ce candidat vaccin anti-VIH, à l'étude depuis plusieurs années semble avoir trouvé sa dose optimale grâce aux travaux de cette équipe de l'Assistance Publique ...

GROSSESSE et TABAGISME: L'étude qui paie les femmes enceintes pour arrêter de fumer - AP-HP

Imposer une amende aux personnes obèses qui n'atteignent pas leur objectif de perte de poids, inciter financièrement les jeunes mamans à allaiter ou les fumeurs à arrê...

Riociguat safe, tolerable in chronic thromboembolic pulmonary hypertension

Patients with chronic thromboembolic pulmonary hypertension tolerated long-term use of riociguat well, according to recent data, and researchers identified two prognostic factors associated with the t...

St. Jude Medical annonce le lancement commercial dans neuf pays européens du nouveau système de cartographie cardiaque Ensite Precision qui porte le marquage CE

Tuesday, April 19th 2016 at 8:29pm UTC D’éminents hôpitaux et laboratoires d’électrophysiologie européens ont adopté l’automatisation, la flexibilité et la précision du systè...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Is the introduction of innovative methods in cardiovascular diagnostics and therapy to quick?

Andreas Grüntzig can be regarded as the pioneer of modern cardiology. Based on the previous experiences of Charles Dotter in Portland, Oregon, and after many years of preparation as a young 38-year-o...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Onco-geriatric Database of Patients With Pancreatic Cancer

This data base has been set in order to gather oncogeriatric information from elderly patients with pancreatic cancer who underwent an oncogeriatric evaluation. ONCOGEPAN database gathers...

Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin

Aldosterone regulation is mediated by hormonal control, and nervous control. Autonomic nervous system action could be mediated by neuropeptides in the adrenal gland. Therefore, in patholog...

Effects of Substance P Antagonists on Adrenal Secretion

Data from the literature and previous in vitro research conducted in the investigators' laboratory (INSERM U413/EA4310, University of Rouen) suggest that adrenal corticosteroid secretion m...

Biological Efficacy of Clopidogrel After Implantation of Drug-Eluting Stents (SPACE)

The risk of thrombotic complications after implantation of drug-eluting stents (DES) may be increased in patients with diabetes mellitus (DM) or metabolic syndrome (MS). It is recommended ...

CYTRAM (Cytochrome P450, Tramadol)

Many methods to detect CYP2D6 poor metabolizers have been validated. Some of them are based on phenotyping (metabolism of dextromethorphan or debrisoquine) and some others on genotyping. U...

Companies [8 Associated Companies listed on BioPortfolio]

CHU - Hôpitaux de Rouen

Nil

Normandie Développement Rouen

An Internationally Renowned French and European Region! 3.2 million inhabitants, 5th biggest French economic region, 2nd largest region for industrial investments per capita, Number one French port c...

Université de Rouen

NIL

PROTEOMIC SOLUTIONS

Founded in 2001, PROTEOMIC SOLUTIONS is a specialized protein lab service located between Paris and Rouen that conducts proteomic projects and practices recombinant protein technology, combined with e...

ANGANY Genetics

ANGANY Genetics is a biotechnology company specialising in the development and production of high quality recombinant allergens for the diagnosis and treatment of allergies. This ...

More Information about "CHU - Hôpitaux de Rouen" on BioPortfolio

We have published hundreds of CHU - Hôpitaux de Rouen news stories on BioPortfolio along with dozens of CHU - Hôpitaux de Rouen Clinical Trials and PubMed Articles about CHU - Hôpitaux de Rouen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CHU - Hôpitaux de Rouen Companies in our database. You can also find out about relevant CHU - Hôpitaux de Rouen Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record